Mark L. Collins

1.1k total citations
16 papers, 853 citations indexed

About

Mark L. Collins is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Mark L. Collins has authored 16 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Mark L. Collins's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and DNA and Nucleic Acid Chemistry (5 papers). Mark L. Collins is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and DNA and Nucleic Acid Chemistry (5 papers). Mark L. Collins collaborates with scholars based in United States, United Kingdom and Japan. Mark L. Collins's co-authors include Carlos Santiago, Lee F. Johnson, Norah A. Terrault, Teresa L. Wright, Jill Detmer, Janice A. Kolberg, C. C. Chang, Thomas Horn, Mário Guimarães Pessôa and Howayda M. Hassoba and has published in prestigious journals such as Nucleic Acids Research, Molecular and Cellular Biology and Hepatology.

In The Last Decade

Mark L. Collins

15 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark L. Collins United States	12	420	237	181	179	103	16	853
Dorothea Sizmann Switzerland	13	391 0.9×	187 0.8×	159 0.9×	171 1.0×	101 1.0×	15	736
Robert Z. Maigetter United States	13	397 0.9×	348 1.5×	185 1.0×	117 0.7×	83 0.8×	26	977
Feng Cao United States	17	172 0.4×	464 2.0×	182 1.0×	354 2.0×	52 0.5×	31	898
Yun Lan China	17	511 1.2×	185 0.8×	248 1.4×	80 0.4×	162 1.6×	90	1.2k
Robert W. King United States	15	239 0.6×	780 3.3×	328 1.8×	572 3.2×	167 1.6×	29	1.1k
Christian Castro United States	14	634 1.5×	295 1.2×	371 2.0×	276 1.5×	88 0.9×	23	1.2k
Ellen Van Damme Belgium	12	238 0.6×	465 2.0×	183 1.0×	119 0.7×	48 0.5×	15	791
Gary Ewart Australia	15	477 1.1×	331 1.4×	702 3.9×	118 0.7×	364 3.5×	24	1.4k
Xuanyong Lu United States	16	246 0.6×	473 2.0×	145 0.8×	319 1.8×	51 0.5×	26	781
Mohsan Saeed United States	19	322 0.8×	402 1.7×	451 2.5×	434 2.4×	60 0.6×	44	1.1k

Countries citing papers authored by Mark L. Collins

Since Specialization

Citations

This map shows the geographic impact of Mark L. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Collins more than expected).

Fields of papers citing papers by Mark L. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Collins. The network helps show where Mark L. Collins may publish in the future.

Co-authorship network of co-authors of Mark L. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Collins. A scholar is included among the top collaborators of Mark L. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Collins. Mark L. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Chahrour, Osama, et al.. (2017). Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉. Journal of Pharmaceutical and Biomedical Analysis. 145. 84–90. 34 indexed citations

Dailey, Peter J., Mark L. Collins, Mickey S. Urdea, & Judith C. Wilber. (2003). Quantification of HCV RNA in Liver Tissue by bDNA Assay. Humana Press eBooks. 19. 119–130. 2 indexed citations

Detmer, Jill, et al.. (2003). Preparation of Genotype-Specific HCV RNA Transcripts for Assessing HCV Detection and Quantification Assays. Humana Press eBooks. 99–112.

Pessôa, Mário Guimarães, Norah A. Terrault, Jill Detmer, et al.. (1998). Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology. 27(3). 877–880. 98 indexed citations

Pessôa, Mário Guimarães, Norah A. Terrault, Linda D. Ferrell, et al.. (1998). Hepatitis after liver transplantation: The role of the known and unknown viruses. Liver Transplantation and Surgery. 4(6). 461–468. 21 indexed citations

Lau, Johnson Y. N., Keping Qian, Jill Detmer, et al.. (1997). Effect of Interferoh α and Ribavirin Therapy on Serum GB Virus C/Hepatiti G Virus (GBV‐C/HGV) RNA Levels in Patients Chronical Infected with Hepatitis C Virus and GBV‐C/HGV. The Journal of Infectious Diseases. 176(2). 421–426. 22 indexed citations

Terrault, Norah A., Peter J. Dailey, Linda D. Ferrell, et al.. (1997). Hepatitis C virus: Quantitation and distribution in liver. Journal of Medical Virology. 51(3). 217–224. 45 indexed citations

Collins, Mark L.. (1997). A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Research. 25(15). 2979–2984. 260 indexed citations

Terrault, Norah A., Peter J. Dailey, Linda D. Ferrell, et al.. (1997). Hepatitis C virus: Quantitation and distribution in liver. Journal of Medical Virology. 51(3). 217–224. 2 indexed citations

10.

Horn, Thomas, C. C. Chang, & Mark L. Collins. (1995). Hybridization properties of the 5-methyl-isocytidine/isoguanosine base pair in synthetic oligodeoxynucleotides. Tetrahedron Letters. 36(12). 2033–2036. 48 indexed citations

11.

Morrissey, Dylan, et al.. (1989). Nucleic acid hybridization assays employing dA-tailed capture probes. Analytical Biochemistry. 181(2). 345–359. 50 indexed citations

12.

Collins, Mark L., et al.. (1989). Nucleic acid hybridization assays employing dA-tailed capture probes. Analytical Biochemistry. 181(2). 360–370. 31 indexed citations

13.

Collins, Mark L., et al.. (1989). Nucleic acid hybridization assays employing dA-tailed capture probes. Single capture methods. Molecular and Cellular Probes. 3(2). 189–207. 22 indexed citations

14.

Collins, Mark L., et al.. (1985). Improved hybridization assays employing tailed oligonucleotide probes: A direct comparison with 5′-end-labeled oligonucleotide probes and nick-translated plasmid probes. Analytical Biochemistry. 151(2). 211–224. 142 indexed citations

15.

Santiago, Carlos, Mark L. Collins, & Lee F. Johnson. (1984). In vitro and in vivo analysis of the control of dihydrofolate reductase gene transcription in serum‐stimulated mouse fibroblasts. Journal of Cellular Physiology. 118(1). 79–86. 67 indexed citations

16.

Collins, Mark L., et al.. (1983). Delayed Processing of Dihydrofolate Reductase Heterogeneous Nuclear RNA in Amino Acid-Starved Mouse Fibroblasts. Molecular and Cellular Biology. 3(10). 1792–1802. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact